Depression and psychotic disorders elevate inpatient burden after posterior cervical decompression and fusion: Prioritizing screening and targeted discharge planning Authors: Leonidas E. Mastrokostas, Paul G. Mastrokostas, Daniel Yusupov, Abigail Razi, Aaron B. Lavi, Luke B. Schwartz, Sean Inzerillo, Mohamed Said, Alexander Kucherina, Pemla Jagtiani, Arie Monas, John K. Houten, Christopher K. Kepler, Jad Bou Monsef, Afshin E. Razi, Mitchell K. Ng Published: 2026 ABSTRACT ABSTRACTContext:Psychiatric comorbidity has been associated with worse perioperative outcomes and greater healthcare utilization after spine surgery.Aims:This study compared complications and healthcare utilization among posterior cervical decompression and fusion (PCDF) patients with depression, psychotic disorders, or no mental-health diagnosis.Settings and Design:Retrospective cohort analysis of the National Inpatient Sample from 2016 to 2022.Materials and Methods:The database was queried for elective adult PCDF encounters. Mental-health exposures were defined using Elixhauser indicators for depression and psychoses. Outcomes included medical complications, non-routine discharge, inpatient mortality, length of stay (LOS), and costs.Statistical Analysis Used:Chi-square and multivariate logistic regression analyses were performed. Significance was set at the P < 0.05 level.Results:We identified 167,480 weighted admissions: 129,205 with no mental-health diagnosis, 32,500 with depression, and 5,775 with psychotic disorders. Depression was associated with higher odds of cardiovascular complications (odds ratio [OR]: 1.20, P < 0.001), mechanical complications (OR: 1.24, P < 0.001), a composite adverse-event outcome (OR: 1.17, P < 0.001), and nonroutine discharge (OR: 1.12, P < 0.001). Psychotic disorders were associated with higher odds of mechanical complications (OR: 1.44, P = 0.002), nonroutine discharge (OR: 1.32, P < 0.001), and inpatient mortality (OR: 2.33, P = 0.043). Costs were higher with depression and highest with psychotic disorders ($39,564 vs. $40,787 vs. $42,362; P < 0.001). LOS was higher with depression and highest with psychotic disorders (4.10 vs. 4.36 vs. 4.81 days; P < 0.001).Conclusions:Depression and psychotic disorders are common in PCDF and are linked to worse outcomes and higher resource use. INTRODUCTION Degenerative cervical myelopathy is a leading cause of adult spinal cord dysfunction and is often managed surgically when progressive neurologic deficits, multilevel stenosis, kyphotic alignment, or instability are present.[1] Posterior cervical decompression and fusion (PCDF) enables multilevel decompression and stabilization but restricts motion and may predispose to adjacent segment disease.[23] Timely decompression is supported to prevent neurological decline and tailor treatment to disease severity, with PCDF frequently favored in multilevel disease.[23] Psychiatric comorbidity has been linked to worse perioperative and utilization outcomes in spine surgery. Menendez et al. reported poorer outcomes and greater need for nonstandard postoperative care among patients with psychiatric diagnoses.[4] Preoperative depression or anxiety is associated with increased early emergency department visits and readmissions after anterior cervical discectomy and fusion, as well as higher 2-year revision rates, greater postoperative opioid use, and higher 1–2-year payments.[56] Aghajanian et al.’s meta-analysis found elevated risks of delirium, thromboembolism, surgical-site infection, neurological injury, non-routine discharge, readmission, and reoperation among patients with depression.[7] Registry data from Deshpande et al. similarly demonstrate worse patient-reported outcomes and higher readmissions, with additive risk when depression and anxiety co-occur.[8] National lumbar fusion samples show higher odds of select perioperative complications and longer length of stay (LOS), though not universally across complication types.[9] Conversely, prospective and retrospective cervical cohorts suggest baseline mental health does not consistently determine the magnitude of postoperative improvement.[1011] Overall, most studies aggregate procedures or emphasize anterior cervical and lumbar fusion procedures, limiting inference about PCDF-specific perioperative risks and resource needs.[1213] To address this gap, we conducted a national analysis of adults undergoing PCDF. Our aims were to: (1) describe the prevalence and patient/hospital profiles of depression and psychotic disorders, (2) quantify their independent associations with perioperative outcomes, and (3) compare resource use across groups. We hypothesized that, relative to controls, patients with depression or psychotic disorders would experience higher rates of perioperative complications, more non-routine discharges, longer hospital stays, and greater costs. MATERIALS AND METHODS Data source We conducted a retrospective observational study using the National Inpatient Sample (NIS) from 2016 to 2022, a 20% stratified sample of discharges from U.S. community hospitals that excludes rehabilitation and long-term acute care facilities.[14] The NIS contains de-identified, publicly available data. Therefore, informed consent was not required, and the study was exempt from Institutional Review Board oversight. Cohort identification and exclusion criteria Adults (≥18 years) who underwent PCDF were identified using ICD-10-PCS procedure codes capturing single-level and multilevel posterior cervical fusion (posterolateral and posterior interbody constructs) performed via an open approach. Encounters were linked to year-appropriate hospital files and cost-to-charge ratios (CCRs). We excluded nonelective admissions; records with missing or implausible age, essential hospital characteristics, or cost data; missing primary payer; and procedures not performed on the admission day. Encounters with negative costs or negative LOS were also excluded. Mental health exposure and comorbidities Mental health exposures were defined using Elixhauser indicators mapped from ICD-10-CM: Depression and psychoses. Patients were classified into mutually exclusive groups – Psychoses, Depression, or Control (neither condition). To avoid collinearity with the exposures, we calculated an Elixhauser Comorbidity Index (ECI) as the row-wise sum of Elixhauser comorbidities with depression and psychoses removed. Outcomes Perioperative complications were identified from ICD-10 diagnosis and procedure codes and summarized into cardiovascular, respiratory, and neurological categories. Individual events relevant to PCDF, including mechanical complications/implant-related events, wound complications (infection/disruption), sepsis, dural tear/cerebrospinal fluid leak, and inpatient mortality, were also assessed. A composite adverse-event indicator flagged the presence of ≥1 complication. Discharge disposition was categorized as routine (home) versus nonroutine (transfer to another facility, skilled nursing, intermediate care, or home health). Deaths were analyzed separately and not excluded based on discharge code. Cost conversion and inflation adjustment Total hospital charges were converted to costs using hospital and year-specific CCRs and then adjusted to 2022 U.S. dollars using Consumer Price Index multipliers. Survey design and statistical analysis All analyses incorporated the complex survey design of the NIS (stratification, clustering, and discharge weights) to generate national estimates. We compared demographic, hospital, and clinical characteristics across mental-health groups using survey-weighted Chi-square tests for categorical variables and survey-weighted linear models for continuous variables. Primary analyses used survey-weighted logistic regression to estimate associations for depression versus control and psychoses versus control with grouped complications, wound complications, mechanical complications, sepsis, neurological complications, the composite adverse event, nonroutine discharge, and inpatient mortality. Models adjusted for age, sex, race, income quartile, primary payer, hospital region, hospital size, teaching status, ECI, and PCDF level (single vs. multilevel). As an exploratory analysis, we compared psychoses versus depression for the same outcomes. Costs and LOS were compared across the three groups using survey-weighted means and global tests with the mental-health group as the factor. Statistical significance was set at P < 0.05. Analyses were conducted in R (version 4.4.0; R Project for Statistical Computing, Vienna, Austria). RESULTS Patient demographics We identified 167,480 weighted PCDF admissions from 2016 to 2022: 129,205 without mental-health comorbidity, 32,500 with depression, and 5,775 with psychotic disorders. Mean age differed across groups (63.31 vs. 61.75 vs. 58.46 years; P < 0.001). Fusion level distribution was similar (single-level: 16.8% vs. 16.6% vs. 16.7%; multilevel: 83.2% vs. 83.4% vs. 83.3%; P = 0.915). Patients with depression and psychotic disorders were more often female than controls (female: 42.8% vs. 60.8% vs. 58.5%; P < 0.001). Racial composition differed (White: 75.2% vs. 83.7% vs. 81.5%; Black: 14.2% vs. 8.3% vs. 10.5%; P < 0.001). Mental-illness cohorts were predominantly treated in urban teaching hospitals (84.2% vs. 83.3% vs. 86.8%; P = 0.043) with modest differences in hospital size (P = 0.001) and region (P < 0.001). Payer mix varied (Medicare: 51.6% vs. 54.0% vs. 54.2%; Medicaid: 8.2% vs. 10.3% vs. 19.5%; P < 0.001). Comorbidity burden was higher in both mental-illness groups (mean ECI: 2.00 vs. 2.46 vs. 2.66; P < 0.001) [Table 1]. Table 1Demographic information for patients undergoing posterior cervical decompression and fusionDemographicsNo mental health comorbidity (n=129,205), n (%)Depression (n=32,500), n (%)Psychotic disorders (n=5775), n (%) P Average age (years)63.3161.7558.46 <0.001 Levels fused Single-level21,765 (16.8)5405 (16.6)965 (16.7)0.915 Multilevel107,440 (83.2)27,095 (83.4)4810 (83.3)Sex Male73,925 (57.2)12,750 (39.2)2395 (41.5) <0.001 Female55,280 (42.8)19,750 (60.8)3380 (58.5)Race White97,115 (75.2)27,200 (83.7)4,705 (81.5) <0.001 Black18,375 (14.2)2710 (8.3)605 (10.5) Hispanic7425 (5.7)1505 (4.6)265 (4.6) Asian or Pacific2645 (2.0)270 (0.8)n≤10* Native American740 (0.6)185 (0.6)n≤10* Other2,905 (2.2)630 (1.9)110 (1.9)Income quartile 0–25th percentile32,565 (25.2)7865 (24.2)1560 (27.0) <0.001 26th–50th percentile33,480 (25.9)9090 (28.0)1625 (28.1) 51st–75th percentile32,970 (25.5)8460 (26.0)1480 (25.6) 76th–100th percentile30,190 (23.4)7085 (21.8)1110 (19.2)Hospital teaching status Rural3610 (2.8)900 (2.8)150 (2.6) 0.043 Urban nonteaching16,795 (13.0)4535 (14.0)610 (10.6) Urban teaching108,800 (84.2)27,065 (83.3)5015 (86.8)Hospital size Small22,640.0 (17.5)6270.0 (19.3)855.0 (14.8) 0.001 Medium30,040.0 (23.2)7060.0 (21.7)1480.0 (25.6) Large76,525.0 (59.2)19,170.0 (59.0)3440.0 (59.6)Hospital region Northeast25,325 (19.6)6050 (18.6)1015 (17.6) <0.001 Midwest30,245 (23.4)8860 (27.3)1635 (28.3) South49,795 (38.5)12,220 (37.6)1925 (33.3) West23,840 (18.5)5370 (16.5)1200 (20.8)Payer status Medicare66,685 (51.6)17,555 (54.0)3130 (54.2) <0.001 Medicaid10,590 (8.2)3335 (10.3)1125 (19.5) Private insurance42,980 (33.3)9640 (29.7)1200 (20.8) Self-pay1120 (0.9)310 (1.0)60 (1.0) Other7830 (6.1)1660 (5.1)260 (4.5) Mean Elixhauser index2.00 (1.52)2.46 (1.60)2.66 (1.64) <0.001 *Signifies that the count number is <10 and cannot be reported. Bolded P values are statistically significant. PCDF - Posterior cervical decompression and fusion; n - Weighted case volume Demographic information for patients undergoing posterior cervical decompression and fusion *Signifies that the count number is <10 and cannot be reported. Bolded P values are statistically significant. PCDF - Posterior cervical decompression and fusion; n - Weighted case volume Prevalence of comorbidities Compared with controls, depression and psychotic-disorder cohorts had higher rates of congestive heart failure (4.3% vs. 5.4% vs. 5.5%; P < 0.001), chronic lung disease (19.4% vs. 30.1% vs. 39.5%; P < 0.001), mild liver disease (2.6% vs. 4.1% vs. 7.1%; P < 0.001), neurological disorders (3.3% vs. 4.5% vs. 6.3%; P < 0.001), obesity (19.7% vs. 25.6% vs. 24.3%; P < 0.001), alcohol abuse (1.9% vs. 2.8% vs. 5.5%; P < 0.001), and drug abuse (1.7% vs. 4.0% vs. 7.2%; P < 0.001). Severe renal failure was similar across groups (1.5% vs. 1.3% vs. 1.2%; P = 0.585) [Table 2]. Table 2Prevalence of comorbiditiesComorbiditiesNo mental health comorbidity (n=129,205), n (%)Depression (n=32,500), n (%)Psychotic Disorders (n=5775), n (%) P Congestive heart failure5510 (4.3)1755 (5.4)320 (5.5) <0.001 Chronic lung disease25,130 (19.4)9770 (30.1)2280 (39.5) <0.001 Mild liver disease3380 (2.6)1325 (4.1)410 (7.1) <0.001 Neurological disorders4255 (3.3)1450 (4.5)365 (6.3) <0.001 Severe renal failure1885 (1.5)430 (1.3)70 (1.2)0.585Obesity25,425 (19.7)8320 (25.6)1405 (24.3) <0.001 Alcohol abuse2410 (1.9)925 (2.8)315 (5.5) <0.001 Drug abuse2145 (1.7)1300 (4.0)415 (7.2) <0.001 Bolded P values are statistically significant Prevalence of comorbidities Bolded P values are statistically significant Unadjusted complications and discharge disposition Unadjusted complication rates were higher in both mental-illness cohorts compared with controls for cardiovascular events (11.4% vs. 14.6% vs. 14.6%; P < 0.001), neurological complications (3.5% vs. 4.0% vs. 4.8%; P = 0.030), and mechanical complications (4.6% vs. 6.2% vs. 8.0%; P < 0.001). Dysphagia (4.9% vs. 5.4% vs. 5.1%; P = 0.227), respiratory complications (0.9% vs. 1.0% vs. 1.0%; P = 0.656), and sepsis (P = 0.388) were not different. The composite adverse-event rate was higher in both cohorts (21.4% vs. 26.6% vs. 27.4%; P < 0.001), and nonroutine discharge was more frequent (45.1% vs. 48.9% vs. 51.3%; P < 0.001). Inpatient mortality was rare; rates differed overall (P = 0.025) [Table 3]. Table 3Complications in patients undergoing posterior cervical decompression and fusionComorbiditiesNo mental health comorbidity, (n=129,205), n (%)Depression (n=32,500), n (%)Psychotic disorders (n=5775), n (%) P Cardiovascular14,750 (11.4)4760 (14.6)845 (14.6) <0.001 Respiratory1185 (0.9)335 (1.0)60 (1.0)0.656Neurological4585 (3.5)1300 (4.0)275 (4.8) 0.030 Dysphagia6305 (4.9)1755 (5.4)295 (5.1)0.227Mechanical complications5890 (4.6)2030 (6.2)460 (8.0) <0.001 Sepsis580 (0.4)130 (0.4)n≤10*0.388Adverse events27,685 (21.4)8635 (26.6)1580 (27.4) <0.001 Discharge disposition58,225 (45.1)15,895 (48.9)2965 (51.3) <0.001 Inpatient mortality355 (0.3)55 (0.2)n≤10* 0.025 * Signifies that the count number is <10 and cannot be reported. Bolded P values are statistically significant. Cardiovascular complications - Transfusion, venous thromboembolism, acute posthemorrhagic anemia, myocardial infarction; Respiratory complications - Pneumonia, pulmonary embolism; Neurological complications - Cerebrovascular accident, nervous system complication, CSF leak/dural tear; Adverse events - 1 or more complications. PCDF - Posterior cervical decompression and fusion; CSF - Cerebrospinal fluid Complications in patients undergoing posterior cervical decompression and fusion * Signifies that the count number is <10 and cannot be reported. Bolded P values are statistically significant. Cardiovascular complications - Transfusion, venous thromboembolism, acute posthemorrhagic anemia, myocardial infarction; Respiratory complications - Pneumonia, pulmonary embolism; Neurological complications - Cerebrovascular accident, nervous system complication, CSF leak/dural tear; Adverse events - 1 or more complications. PCDF - Posterior cervical decompression and fusion; CSF - Cerebrospinal fluid Multivariable regression analysis After adjustment, depression versus control was associated with higher odds of cardiovascular complications (odds ratio [OR]: 1.20, 95% confidence interval [CI] 1.10–1.31, P < 0.001), mechanical complications (OR: 1.24, CI: 1.10–1.40, P < 0.001), composite adverse events (OR: 1.17, CI: 1.10–1.25, P < 0.001), and nonroutine discharge (OR: 1.12, CI: 1.05–1.19, P < 0.001). Associations were not significant for respiratory, neurological, dysphagia, or sepsis; inpatient mortality was not different (OR: 0.63, CI: 0.32–1.23, P = 0.176). Psychotic disorders versus control showed increased odds of mechanical complications (OR: 1.44, CI: 1.14–1.80, P = 0.002) and nonroutine discharge (OR: 1.32, CI: 1.16–1.52, P < 0.001); other outcomes, including cardiovascular, dysphagia, and sepsis, were not significant. Inpatient mortality was higher (OR: 2.33, CI: 1.03–5.30, P = 0.043). In an exploratory head-to-head comparison, psychotic disorders vs depression had higher odds of nonroutine discharge (OR: 1.22, CI: 1.06–1.40, P = 0.006) and inpatient mortality (OR: 3.57, CI: 1.32–9.63, P = 0.012), with no significant differences for other outcomes [Table 4]. Table 4Regression modeling predicting influence of mental illness on inpatient complicationsComplicationsOR (95% CI) P Depression versus no mental health comorbidity† Cardiovascular1.20 (1.10–1.31) <0.001 Respiratory0.98 (0.74–1.30)0.915 Neurological0.99 (0.85–1.14)0.869 Dysphagia1.02 (0.90–1.16)0.751 Mechanical complications1.24 (1.10–1.40) <0.001 Sepsis0.77 (0.49–1.20)0.251 Adverse events1.17 (1.10–1.25) <0.001 Discharge disposition1.12 (1.05–1.19) <0.001 Inpatient mortality0.63 (0.32–1.23)0.176Psychotic disorders versus no mental health comorbidity† Cardiovascular1.13 (0.95–1.35)0.163 Respiratory0.96 (0.52–1.78)0.903 Neurological1.07 (0.80–1.42)0.663 Dysphagia0.90 (0.69–1.19)0.462 Mechanical complications1.44 (1.14–1.80) 0.002 Sepsis1.11 (0.52–2.38)0.786 Adverse events1.11 (0.97–1.28)0.122 Discharge disposition1.32 (1.16–1.52) <0.001 Inpatient mortality2.33 (1.03–5.30) 0.0428 Psychotic disorders versus depression† Cardiovascular0.97 (0.81–1.17)0.771 Respiratory1.00 (0.53–1.89)0.999 Neurological1.20 (0.89–1.62)0.237 Dysphagia0.92 (0.70–1.23)0.586 Mechanical complications1.20 (0.94–1.52)0.142 Sepsis1.53 (0.71–3.31)0.282 Adverse events1.01 (0.87–1.16)0.907 Discharge disposition1.22 (1.06–1.40) 0.006 Inpatient mortality3.57 (1.32–9.63) 0.012 †Reference. Bolded P values are statistically significant. Cardiovascular complications - Transfusion, venous thromboembolism, acute posthemorrhagic anemia, myocardial infarction; Respiratory complications - Pneumonia, pulmonary embolism; Neurological complications - Cerebrovascular accident, nervous system complication, CSF leak/dural tear; Adverse events - 1 or more complications. CI - Confidence interval; OR - Odds ratio; CSF - Cerebrospinal fluid Regression modeling predicting influence of mental illness on inpatient complications †Reference. Bolded P values are statistically significant. Cardiovascular complications - Transfusion, venous thromboembolism, acute posthemorrhagic anemia, myocardial infarction; Respiratory complications - Pneumonia, pulmonary embolism; Neurological complications - Cerebrovascular accident, nervous system complication, CSF leak/dural tear; Adverse events - 1 or more complications. CI - Confidence interval; OR - Odds ratio; CSF - Cerebrospinal fluid Costs and length of stay Mean adjusted hospital costs increased stepwise across groups (controls: $39,564, depression: $40,787, psychotic disorders: $42,362; P < 0.001). LOS followed a similar pattern (4.10 vs. 4.36 vs. 4.81 days; P < 0.001) [Table 5]. Table 5Costs and length of stay for patients undergoing posterior cervical decompression and fusionOutcomesNo mental health comorbidity (n=129,205)Depression (n=32,500)Psychotic disorders (n=5775) P Costs, mean ($)39,564.0340,787.3842,361.97 <0.001 LOS, mean (days)4.104.364.81 <0.001 Bolded P values are statistically significant. PCDF - Posterior cervical decompression and fusion; LOS - Length of stay Costs and length of stay for patients undergoing posterior cervical decompression and fusion Bolded P values are statistically significant. PCDF - Posterior cervical decompression and fusion; LOS - Length of stay DISCUSSION PCDF is a common intervention for multilevel cervical pathology but carries meaningful perioperative risk and resource demands. Because psychiatric illness is prevalent in spine surgery populations, clarifying its impact specifically in PCDF is clinically important. In this national cohort of adults undergoing PCDF, depression and psychotic disorders were prevalent and concentrated in patients with higher comorbidity and greater medicaid coverage. Depression was associated with higher odds of cardiovascular complications, mechanical complications, any adverse event, and nonroutine discharge, while psychotic disorders were linked to higher odds of mechanical complications and nonroutine discharge and uniquely to increased inpatient mortality. Costs and LOS rose stepwise from controls to depression to psychotic disorders. Together, these findings indicate that mental-health comorbidity, particularly psychotic disorders, tracks with greater perioperative risk and resource use in PCDF. Depression and psychotic disorders were prevalent in PCDF and clustered with higher comorbidity and Medicaid coverage. Depression was associated with higher odds of cardiovascular and mechanical complications, any adverse event, and non-routine discharge, whereas psychotic disorders were associated with mechanical complications, nonroutine discharge, uniquely higher inpatient mortality, and stepwise increases in LOS and costs. These patterns mirror procedure-specific PCDF evidence linking depression/anxiety to higher revision rates and diminished Neck Disability Index improvement and align with multicenter lumbar registry data showing worse patient-reported outcomes and higher readmissions, with additive risk when anxiety and depression co-occur.[815] At the same time, cervical literature indicates that although patients with depression present with and maintain worse absolute disease severity, improvements can approximate those of nondepressed cohorts over follow-up.[161718] Both mental-health cohorts had higher rates of mechanical complications and non-routine discharge. Psychotic disorders were additionally associated with increased in-hospital mortality, longer LOS, and higher costs. Consistent with this pattern, Diebo et al. and Dedeogullari et al. reported associations between mental illness and postoperative infection and device-related complications in cervical surgery.[1920] Kamalapathy et al. and Katsnelson et al. also observed higher short-term adverse events and modestly higher reoperation risk after outpatient ACDF in patients with psychiatric disorders, particularly severe mental illness.[621] Preoperative depression has been associated with poorer patient–physician communication that may influence adherence.[22] Psychiatric illness is a recognized risk factor for postoperative delirium, a complication tied to longer stays, higher costs, and in-hospital mortality.[23] Elevated perioperative risk does not appear to reflect greater analgesic needs alone, as additional opioid fills were not increased after single-level cervical fusion in patients with depression/anxiety.[24] These findings support multifactorial pathways involving medical complexity, delirium susceptibility, perioperative engagement, and social barriers to home discharge. Psychotic disorders carried greater odds of nonroutine discharge and inpatient mortality than depression, even after adjustment. Although direct PCDF evidence separating these diagnoses is limited, anterior cervical fusion studies consistently show that more severe psychiatric illness is linked to higher adverse events and reoperation risk than anxiety or depression alone.[619] These distinctions matter for counseling and discharge planning, and patients with psychotic disorders may benefit from earlier case management, proactive delirium prevention, and clear contingency planning for facility-based discharge. It is important to use routine, structured screening for depression and serious mental illness in PCDF candidates. Risk-aligned optimization should treat active symptoms preoperatively, implement delirium-prevention measures for high-risk patients, set expectations with early rehab engagement, and involve social work early to anticipate non-routine discharge. Long-term studies also show that patients with depression or anxiety often achieve meaningful improvement, which supports offering surgery while tailoring perioperative pathways to mitigate short-term risks.[161718] This study has several limitations. The NIS captures only index hospitalizations and lacks clinical granularity, such as levels fused in detail, deformity parameters, prior surgery, bone quality, implant or biologic choices, operative time, and blood loss, as well as surgeon or hospital volume and standardized recovery protocols, all of which influence complications and discharge. Psychiatric diagnoses are claims-based, and the database cannot capture the degree of psychiatric illness severity or depression, treatment status, or adherence, nor does it include validated symptom scales. We could not assess postdischarge events such as 30 or 90-day complications, readmissions, or reoperations, nor long-term function or opioid use, and procedures in ambulatory settings are not captured. Although our models adjusted for many covariates, residual confounding from unmeasured clinical and social factors may remain. CONCLUSION Depression and psychotic disorders were common among patients undergoing PCDF and were associated with higher perioperative risk, including greater odds of mechanical complications and non-routine discharge. Costs and LOS were higher in patients with depression and highest in those with psychotic disorders. These findings highlight the importance of routine mental-health screening and risk-aligned perioperative planning to anticipate complications and discharge needs. Future prospective studies should assess mechanisms, treatment status, and severity, and postdischarge outcomes to identify modifiable targets and optimize care pathways. Conflicts of interest Mitchell K. Ng has the following disclosures: VB Spine Inc. (paid consultant), Stryker Inc. (paid consultant), Johnson and Johnson Ethicon Inc. (paid consultant), Elevation Spine (paid consultant), CurvaFix Inc. (paid consultant), Pacira BioSciences Inc. (paid consultant), Sage Products Inc. (paid consultant), Alafair Biosciences Inc. (paid consultant), Next Science LLC (paid consultant), Bonutti Technologies Inc. (paid consultant), Hippocrates Opportunities Fund LLC (paid consultant), FISSO USA (paid consultant), MM Labs (paid consultant), Ferghana Partners Inc. (paid consultant). Christopher K. Kepler has the following disclosures: Clinical Spine Surgery (editorial or governing board; section editor), Curetiva (IP royalties), Regeneration Technologies, Inc. (IP royalties), Altus Partners LLC (stock), and Harmoni (stock). Afshin E. Razi has the following disclosures: 4D Motion (IP royalties), Clinical Orthopaedic Society (fiduciary officer; president; board of directors/committee member), and New York State Society of Orthopaedic Surgeons (fiduciary officer; secretary; board of directors/committee member). The author(s) declare that there is no conflict of interest and received no financial support for the research, authorship, and/or publication of this article. No IRB approval or informed consent was required for this review.